GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ligand Pharmaceuticals Incorporated (LGND) [hlAlert]

Rating:
Buy LGND
up 492.76 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Feb 12, 2009  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on 02/12/2009, when the stock price was $15.90.
Since then, Ligand Pharmaceuticals Incorporated has gained 492.77% as of 09/30/2015's recent price of $94.25.
If you would have followed this Merriman Curhan Ford's recommendation on LGND, you would have gained 492.76% of your investment in 2421 days.

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/12/2009 8:25 AM Buy
None
15.90
as of 12/31/2009
1 Week up  295.89 %
1 Month up  337.87 %
3 Months up  275.32 %
1 YTD up  227.16 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy